glp 1 cause kidney issues GLP-1 receptor agonists in patients with chronic disease and either overweight or obesity Cardio-renal outcomes in type 2

Watson admitted that clarification surprised him

How to use: - Use twice a day, morning and evening, after bathing

Studies indicate that any reduction in metabolic rate during GLP-1 treatment is primarily attributable to: Decreased body mass : A smaller body naturally requires less energy for basic physiological functions Loss of metabolically active tissue : Both fat and lean tissue contribute to resting energy expenditure Normal adaptive thermogenesis : The body's natural response to caloric restriction and weight loss Comparative studies examining GLP-1-induced weight loss versus equivalent weight loss through diet and exercise show similar metabolic adaptations, suggesting the medications do not cause additional metabolic suppression beyond what would be expected with weight loss by any means

doi: 10.18632/aging.103059 41 HuangS

2.55 events per 1,000 person-years

Effects of a new SGLT2 inhibitor, luseogliflozin, on diabetic nephropathy in T2DN rats